1. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001; 85:430–434. PMID:
11307809.
Article
2. Cho YH, Chae MK, Cha JM, et al. Cerebral venous thrombosis in a patient with Crohn's disease. Intest Res. 2016; 14:96–101. PMID:
26884741.
Article
3. Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis. Continuum (Minneap Minn. 2014; 20:335–351. PMID:
24699485.
Article
4. Katsanos AH, Katsanos KH, Kosmidou M, Giannopoulos S, Kyritsis AP, Tsianos EV. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM. 2013; 106:401–413. PMID:
23243293.
Article
5. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008; 103:2272–2280. PMID:
18684186.
Article
6. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007; 102:174–186. PMID:
17100967.
Article
7. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007; 6:162–170. PMID:
17239803.
Article
8. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35:664–670. PMID:
14976332.
Article
9. Chauhan S, Sachdev A, D'Cruz S, Jain K, Singh R. Cerebral venous thrombosis in a patient with ulcerative colitis. Inflamm Bowel Dis. 2007; 13:1588–1589. PMID:
17663421.
Article
10. Kawanishi M, Yoshida Y, Sakaguchi I, Nagano F, Kato K, Miyake H. Cerebral venous sinus thrombosis in a patient with ulcerative colitis. J Stroke Cerebrovasc Dis. 2003; 12:271–275. PMID:
17903939.
Article
11. Crassard I, Bousser MG. Headache in patients with cerebral venous thrombosis. Rev Neurol (Paris). 2005; 161:706–708. PMID:
16141966.
12. Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2011; 42:1158–1192. PMID:
21293023.
Article
13. Sipeki N, Davida L, Palyu E, et al. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. World J Gastroenterol. 2015; 21:6952–6964. PMID:
26078573.
Article
14. Wasay M, Azeemuddin M. Neuroimaging of cerebral venous thrombosis. J Neuroimaging. 2005; 15:118–128. PMID:
15746223.
Article
15. Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010; 17:1229–1235. PMID:
20402748.
Article
16. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999; 30:484–488. PMID:
10066840.
Article
17. Nudelman RJ, Rosen DG, Rouah E, Verstovsek G. Cerebral sinus thrombosis: a fatal neurological complication of ulcerative colitis. Patholog Res Int. 2010; 2010:132754. DOI:
10.4061/2010/132754. PMID:
21152173.
Article
18. Markowitz RL, Ment LR, Gryboski JD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr. 1989; 8:413–420. PMID:
2651640.
Article
19. Stolz E, Klötzsch C, Schlachetzki F, Rahimi A. High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis. Eur Neurol. 2003; 49:247–248. PMID:
12736545.
Article
20. Richard S, Fairise A, Lacour JC, Ducrocq X. Cerebral venous thrombosis in inflammatory bowel diseases. Inflamm Bowel Dis. 2010; 16:366–367. PMID:
19575358.
Article